6NF7

Crystal Structure of RT1.Aa-Bu31-10

6NF7 の概要

• エントリーDOI: 10.2210/pdb6nf7/pdb
• 分子名称: RT1A.a, Beta-2-microglobulin, Bu31-10 peptide (3 entities in total)
• 機能のキーワード: transplantation, tolerance, cd8+ tregs, rat, mhc, immune system
• 由来する生物種: Rattus norvegicus (Rat); 詳細
• タンパク質・核酸の鎖数: 15
• 化学式量合計: 226833.31

構造登録者

Gras, S. (登録日: 2018-12-19, 公開日: 2019-12-25, 最終更新日: 2024-10-23)

主引用文献

Picarda, E.,Bezie, S.,Usero, L.,Ossart, J.,Besnard, M.,Halim, H.,Echasserieau, K.,Usal, C.,Rossjohn, J.,Bernardeau, K.,Gras, S.,Guillonneau, C.
Cross-Reactive Donor-Specific CD8+Tregs Efficiently Prevent Transplant Rejection.
Cell Rep, 29:4245-4255.e6, 2019

PubMed Abstract: To reduce the use of non-specific immunosuppressive drugs detrimental to transplant patient health, therapies in development aim to achieve antigen-specific tolerance by promoting antigen-specific regulatory T cells (Tregs). However, identification of the natural antigens recognized by Tregs and the contribution of their dominance in transplantation has been challenging. We identify epitopes derived from distinct major histocompatibility complex (MHC) class II molecules, sharing a 7-amino acid consensus sequence positioned in a central mobile section in complex with MHC class I, recognized by cross-reactive CD8 Tregs, enriched in the graft. Antigen-specific CD8 Tregs can be induced in vivo with a 16-amino acid-long peptide to trigger transplant tolerance. Peptides derived from human HLA class II molecules, harboring the rat consensus sequence, also activate and expand human CD8 Tregs, suggesting its potential in human transplantation. Altogether, this work should facilitate the development of therapies with peptide epitopes for transplantation and improve our understanding of CD8 Treg recognition.

PubMed: 31875536
DOI: 10.1016/j.celrep.2019.11.106

実験手法

X-RAY DIFFRACTION (2.9 Å)